1. Home
  2. HBIO vs NAII Comparison

HBIO vs NAII Comparison

Compare HBIO & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBIO
  • NAII
  • Stock Information
  • Founded
  • HBIO 1901
  • NAII 1980
  • Country
  • HBIO United States
  • NAII United States
  • Employees
  • HBIO N/A
  • NAII N/A
  • Industry
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • HBIO Industrials
  • NAII Health Care
  • Exchange
  • HBIO Nasdaq
  • NAII Nasdaq
  • Market Cap
  • HBIO 22.5M
  • NAII 21.1M
  • IPO Year
  • HBIO 2000
  • NAII 1987
  • Fundamental
  • Price
  • HBIO $0.51
  • NAII $3.46
  • Analyst Decision
  • HBIO Buy
  • NAII
  • Analyst Count
  • HBIO 2
  • NAII 0
  • Target Price
  • HBIO $3.00
  • NAII N/A
  • AVG Volume (30 Days)
  • HBIO 35.3M
  • NAII 3.8K
  • Earning Date
  • HBIO 08-07-2025
  • NAII 05-14-2025
  • Dividend Yield
  • HBIO N/A
  • NAII N/A
  • EPS Growth
  • HBIO N/A
  • NAII N/A
  • EPS
  • HBIO N/A
  • NAII N/A
  • Revenue
  • HBIO $91,397,000.00
  • NAII $125,483,000.00
  • Revenue This Year
  • HBIO N/A
  • NAII N/A
  • Revenue Next Year
  • HBIO $9.75
  • NAII N/A
  • P/E Ratio
  • HBIO N/A
  • NAII N/A
  • Revenue Growth
  • HBIO N/A
  • NAII 4.39
  • 52 Week Low
  • HBIO $0.28
  • NAII $2.57
  • 52 Week High
  • HBIO $3.60
  • NAII $6.88
  • Technical
  • Relative Strength Index (RSI)
  • HBIO 54.14
  • NAII 58.05
  • Support Level
  • HBIO $0.47
  • NAII $3.31
  • Resistance Level
  • HBIO $0.55
  • NAII $3.49
  • Average True Range (ATR)
  • HBIO 0.07
  • NAII 0.08
  • MACD
  • HBIO -0.00
  • NAII -0.01
  • Stochastic Oscillator
  • HBIO 50.68
  • NAII 72.73

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: